BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Finance Desk//Catalysts//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Finance Desk catalysts
X-PUBLISHED-TTL:PT1H
REFRESH-INTERVAL;VALUE=DURATION:PT1H
BEGIN:VEVENT
UID:fd-catalyst-2393@financedesk
DTSTAMP:20261014T024657Z
DTSTART;VALUE=DATE:20261231
SUMMARY:Dazodalibep Phase 3 Sjögren's studies complete (est.)
DESCRIPTION:Estimated date.\nDazodalibep\, Amgen\nhttps://wiremeridian.com
 /c/amgen/dazodalibep
URL:https://wiremeridian.com/c/amgen/dazodalibep
STATUS:TENTATIVE
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR